BridgeMD
New treatment option for Breast Cancer
Official title Effects of Neoadjuvant Prehabilitation on Post-Interventional Physical and Psychological Outcomes in Oncology Patients With Solid Tumors
ClinicalTrials.gov ID: NCT07464457
What this study is testing
- What it's testing
- The goal of NEOPRO-SIT is to establish and evaluate a neoadjuvant prehabilitation program comprised of targeted exercise therapy and structured psycho-oncological support in patients with solid tumors. The main question is: Will targeted exercise therapy and structured psycho-oncological support increase both physical and psychological capacity as well of quality of life compared to standard of care in a prehabilitation setting?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients with solid tumors (focus on breastcancer)
- Curative-intent multimodal treatment concept with local surgical or radiotherapeutic ablation
- Working age and \> 18 years
- ECOG 0-2
- Sufficient language skills to understand questionnaires/training instructions
You likely can't join if
- Severe cardiac or pulmonary comorbidities that do not allow participation in the program
- Medical contraindications for physical activity
- Lack of patient capacity to consent
- Pregnancy/breastfeeding
- Acute infections/fever
- Participation in another clinical intervention study
The study team makes the final eligibility decision.
Where it's taking place
- Münster, North Rhine-Westphalia, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Münster, North Rhine-Westphalia, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.